家庭用睡眠時無呼吸症候群検査デバイスの世界市場 (2022-2028年)：市場予測 (タイプ2・3・4別)・地域的展望・用途の潜在性・市場シェア

家庭用睡眠時無呼吸症候群検査デバイスの市場は、睡眠モニタリング手法や検査デバイスの採用が進んでいることから、2028年にかけて大きく成長すると予測されています。

また、先端技術に関するR&D費の増加も予測期間を通じて市場の成長を促進する可能性があります。

検査タイプ別で見ると、タイプ4の部門が2021年に約24％の市場シェアを占め、複数の睡眠障害の検査における利点や、認知度の上昇から、堅調な成長を示しています。また、地域別では、ラテンアメリカ地域が2021年に9,100万米ドル超を示し、予測期間中も高い成長を示す可能性が高いと考えられています。この成長は、同地域における高齢者人口の増加と、睡眠時無呼吸症候群やその他の睡眠障害に関する認知度の向上に起因しています。

当レポートでは、世界の家庭用睡眠時無呼吸症候群検査デバイスの市場を調査し、市場の定義と概要、新型コロナウイルス感染症 (COVID-19) およびその他の市場影響因子の分析、法規制・償還環境、技術動向、市場規模の推移・予測、各種区分・地域/主要国別の内訳、競合環境、主要企業のプロファイルなどをまとめています。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

第3章 家庭用睡眠時無呼吸症候群検査デバイス産業の考察

• 産業の分類
• 産業情勢
• 産業への影響要因
  • 成長要因
  • 潜在的リスク＆課題
• 成長の可能性の分析
• COVID-19：影響分析
• 規制状況
• 償還シナリオ
• 技術情勢
• ポーターの分析
• 競合情勢
• PESTEL分析

第4章 家庭用睡眠時無呼吸症候群検査デバイス市場：検査タイプ別

• 主要動向
• タイプ2
• タイプ3
• タイプ4

第5章 家庭用睡眠時無呼吸症候群検査デバイス市場：地域別

• 主要動向
• 北米
• 欧州
• アジア太平洋
• ラテンアメリカ
• 中東・アフリカ

第6章 企業プロファイル

• 競合ダッシュボード
• Compumedics Limited
• Cadwell Laboratories Inc.
• CleveMed
• Contec Medical Systems
• Itamar Medical Inc.
• Koninklijke Philips N.V.
• Natus Medical Inc.
• Neurosoft
• NeuroVirtual/SleepVirtual
• Nihon Kohden Corporation
• Nox Medical
• Resmed
• SleepMed
• SOMNOmedics GmbH

Data Tables

• TABLE 1. Global home sleep apnea testing devices market, 2017 - 2021 (USD Million)
• TABLE 2. Global home sleep apnea testing devices market, 2022 - 2028 (USD Million)
• TABLE 3. Global home sleep apnea testing devices market, by test type, 2017 - 2021 (USD Million)
• TABLE 4. Global home sleep apnea testing devices market, by test type, 2022 - 2028 (USD Million)
• TABLE 5. Global home sleep apnea testing devices market, by region, 2017 - 2021 (USD Million)
• TABLE 6. Global home sleep apnea testing devices market, by region, 2022 - 2028 (USD Million)
• TABLE 7. Industry impact forces
• TABLE 8. Type 2 market size, by region, 2017 - 2021 (USD Million)
• TABLE 9. Type 2 market size, by region, 2022 - 2028 (USD Million)
• TABLE 10. Type 3 market size, by region, 2017- 2021 (USD Million)
• TABLE 11. Type 3 market size, by region, 2022 - 2028 (USD Million)
• TABLE 12. Type 4 market size, by region, 2017 - 2021 (USD Million)
• TABLE 13. Type 4 market size, by region, 2022 - 2028 (USD Million)
• TABLE 14. North America home sleep apnea testing devices market size, by country, 2017 - 2021 (USD Million)
• TABLE 15. North America home sleep apnea testing devices market size, by country, 2022 - 2028 (USD Million)
• TABLE 16. North America home sleep apnea testing devices market size, by test type, 2017 - 2021 (USD Million)
• TABLE 17. North America home sleep apnea testing devices market size, by test type, 2022 - 2028 (USD Million)
• TABLE 18. U.S. home sleep apnea testing devices market size, by test type, 2017 - 2021 (USD Million)
• TABLE 19. U.S. home sleep apnea testing devices market size, by test type, 2022 - 2028 (USD Million)
• TABLE 20. Canada home sleep apnea testing devices market size, by test type, 2017 - 2021 (USD Million)
• TABLE 21. Canada home sleep apnea testing devices market size, by test type, 2022 - 2028 (USD Million)
• TABLE 22. Europe home sleep apnea testing devices market size, by country, 2017 - 2021 (USD Million)
• TABLE 23. Europe home sleep apnea testing devices market size, by country, 2022 - 2028 (USD Million)
• TABLE 24. Europe home sleep apnea testing devices market size, by test type, 2017 - 2021 (USD Million)
• TABLE 25. Europe home sleep apnea testing devices market size, by test type, 2022 - 2028 (USD Million)
• TABLE 26. Germany home sleep apnea testing devices market size, by test type, 2017 - 2021 (USD Million)
• TABLE 27. Germany home sleep apnea testing devices market size, by test type, 2022 - 2028 (USD Million)
• TABLE 28. UK home sleep apnea testing devices market size, by test type, 2017 - 2021 (USD Million)
• TABLE 29. UK home sleep apnea testing devices market size, by test type, 2022 - 2028 (USD Million)
• TABLE 30. France home sleep apnea testing devices market size, by test type, 2017 - 2021 (USD Million)
• TABLE 31. France home sleep apnea testing devices market size, by test type, 2022 - 2028 (USD Million)
• TABLE 32. Italy home sleep apnea testing devices market size, by test type, 2017 - 2021 (USD Million)
• TABLE 33. Italy home sleep apnea testing devices market size, by test type, 2022 - 2028 (USD Million)
• TABLE 34. Spain home sleep apnea testing devices market size, by test type, 2017 - 2021 (USD Million)
• TABLE 35. Spain home sleep apnea testing devices market size, by test type, 2022 - 2028 (USD Million)
• TABLE 36. Asia Pacific home sleep apnea testing devices market size, by country, 2017 - 2021 (USD Million)
• TABLE 37. Asia Pacific home sleep apnea testing devices market size, by country, 2022 - 2028 (USD Million)
• TABLE 38. Asia Pacific home sleep apnea testing devices market size, by test type, 2017 - 2021 (USD Million)
• TABLE 39. Asia Pacific home sleep apnea testing devices market size, by test type, 2022 - 2028 (USD Million)
• TABLE 40. China home sleep apnea testing devices market size, by test type, 2017 - 2021 (USD Million)
• TABLE 41. China home sleep apnea testing devices market size, by test type, 2022 - 2028 (USD Million)
• TABLE 42. Japan home sleep apnea testing devices market size, by test type, 2017 - 2021 (USD Million)
• TABLE 43. Japan home sleep apnea testing devices market size, by test type, 2022 - 2028 (USD Million)
• TABLE 44. India home sleep apnea testing devices market size, by test type, 2017 - 2021 (USD Million)
• TABLE 45. India home sleep apnea testing devices market size, by test type, 2022 - 2028 (USD Million)
• TABLE 46. Australia home sleep apnea testing devices market size, by test type, 2017 - 2021 (USD Million)
• TABLE 47. Australia home sleep apnea testing devices market size, by test type, 2022 - 2028 (USD Million)
• TABLE 48. South Korea home sleep apnea testing devices market size, by test type, 2017 - 2021 (USD Million)
• TABLE 49. South Korea home sleep apnea testing devices market size, by test type, 2022 - 2028 (USD Million)
• TABLE 50. Latin America home sleep apnea testing devices market size, by country, 2017 - 2021 (USD Million)
• TABLE 51. Latin America home sleep apnea testing devices market size, by country, 2022 - 2028 (USD Million)
• TABLE 52. Latin America home sleep apnea testing devices market size, by test type, 2017 - 2021 (USD Million)
• TABLE 53. Latin America home sleep apnea testing devices market size, by test type, 2022 - 2028 (USD Million)
• TABLE 54. Brazil home sleep apnea testing devices market size, by test type, 2017 - 2021 (USD Million)
• TABLE 55. Brazil home sleep apnea testing devices market size, by test type, 2022 - 2028 (USD Million)
• TABLE 56. Mexico home sleep apnea testing devices market size, by test type, 2017 - 2021 (USD Million)
• TABLE 57. Mexico home sleep apnea testing devices market size, by test type, 2022 - 2028 (USD Million)
• TABLE 58. Argentina home sleep apnea testing devices market size, by test type, 2017 - 2021 (USD Million)
• TABLE 59. Argentina home sleep apnea testing devices market size, by test type, 2022 - 2028 (USD Million)
• TABLE 60. MEA home sleep apnea testing devices market size, by test type, 2017 - 2021 (USD Million)
• TABLE 61. MEA home sleep apnea testing devices market size, by test type, 2022 - 2028 (USD Million)
• TABLE 62. South Africa home sleep apnea testing devices market size, by test type, 2017 - 2021 (USD Million)
• TABLE 63. South Africa home sleep apnea testing devices market size, by test type, 2022 - 2028 (USD Million)
• TABLE 64. Saudi Arabia home sleep apnea testing devices market size, by test type, 2017 - 2021 (USD Million)
• TABLE 65. Saudi Arabia home sleep apnea testing devices market size, by test type, 2022 - 2028 (USD Million)
• TABLE 66. UAE home sleep apnea testing devices market size, by test type, 2017 - 2021 (USD Million)
• TABLE 67. UAE home sleep apnea testing devices market size, by test type, 2022 - 2028 (USD Million)

Charts & Figures

• FIG. 1 Top-down approach (Supply side analysis)
• FIG. 2 Data Validation
• FIG. 3 Home sleep apnea testing devices market size, 2017 -2028 (USD Million)
• FIG. 4 Industry segmentation
• FIG. 5 Global home sleep apnea testing devices market, 2017-2028 (USD Million)
• FIG. 6 Growth potential analysis, by test type
• FIG. 7 Porter's analysis
• FIG. 8 Company matrix analysis, 2021
• FIG. 9 PESTEL analysis
• FIG. 10 Key segment trends, by test type
• FIG. 11 Key regional trends
• FIG. 12 Competitive dashboard, 2021

The home sleep apnea testing devices market is set to observe massive growth by 2028 due to growing adoption of sleep monitoring methods and testing devices. Additionally, rising R&D expenses on advanced technologies are also likely to fuel the market growth through the forecast timeline.

Recently, government agencies have been collaborating with public organizations to initiate public education, awareness campaigns, and training programs for clinicians, which has played a vital role in industry growth. For instance, in February 2021, the U.S. Food and Drug Administration (FDA) approved a tongue strengthening device that stimulates tongue movement and avoids sleep apnea in patients. The device works on an innovative technology that is used while the patient is awake unlike most devices that are used during sleeping hours.

Similarly, in April 2022, U.S. FDA approved a tongue stimulator sleep apnea testing device that treats sleep apnea in children with down syndrome. The device claims to automatically move the tongue and clear the air pathway by sending a signal to the hypoglossal nerve to breathe.

Furthermore, major players in the industry have been engaging in collaborations and partnerships while also focusing on various R&D activities to realize innovations in sleep monitoring devices to expand their presence in the sector, thereby propelling home sleep apnea testing devices market growth. For instance, in December 2020, ResMed, a U.S.-based manufacturer of sleep apnea testing devices, introduced a novel treatment approach for sleep apnea in patients with their new ResMed remote diagnostic technology that ensures healthy sleep movements and aids in the detection of any casualties at home.

In another instance, in February 2022, Compumedics Limited, a specialist in the diagnosis of sleeping disorders, in collaboration with Radiometer Pacific, an Australia-based manufacturer of transcutaneous monitoring systems, became the official distributor of Radiometer's TCM5 Flex transcutaneous monitor in Australia and New Zealand. The device detects hypoventilation in patients at risk of sleep-related breathing disorders.

The home sleep apnea testing devices market has been bifurcated based on test type and region. In terms of test type, the market has been further divided into type 2, type 3, and type 4. In 2021, the type 4 segment held approximately 24% market share and is primed to witness robust growth on account of soaring demand and rising awareness regarding benefits offered by type 4 home sleep apnea testing devices in the testing of multiple sleep disorders.

In the regional landscape, the Latin America home sleep apnea testing devices market was valued at more than USD 91 million in 2021 and is likely to witness notable growth between 2022 and 2028. This growth is attributable to the growing aging population and increasing awareness regarding sleep apnea and other sleep disorders in the LATAM region.

Table of Contents

Chapter 1 Methodology

• 1.1 Market definitions
• 1.2 Base estimates & working
• 1.3 Forecast calculations
• 1.4 Data validation
• 1.5 Data sources
  • 1.5.1 Secondary
    • 1.5.1.1 Paid sources
    • 1.5.1.2 Unpaid sources
  • 1.5.2 Primary

Chapter 2 Executive Summary

• 2.1 Home sleep apnea testing devices industry 360 degree synopsis, 2017 - 2028
  • 2.1.1 Business trends
  • 2.1.2 Test type trends
  • 2.1.3 Regional Trends

Chapter 3 Home Sleep Apnea Testing Devices Industry Insights

• 3.1 Industry segmentation
• 3.2 Industry landscape, 2017 - 2028 (USD Million)
• 3.3 Industry impact forces
  • 3.3.1 Growth drivers
    • 3.3.1.1 Growing prevalence of sleep apnea and related co-morbidities
    • 3.3.1.2 Increasing awareness regarding home sleep apnea tests
    • 3.3.1.3 Increasing aging population
    • 3.3.1.4 Product innovation strategy adopted by key industry players
  • 3.3.2 Industry pitfalls & challenges
    • 3.3.2.1 Clinical consequences and economic impact of sleep apnea and related sleep disorders
    • 3.3.2.2 Stringent regulations
• 3.4 Growth potential analysis
  • 3.4.1 By test type
• 3.5 COVID-19 impact analysis
• 3.6 Regulatory landscape
• 3.7 Reimbursement scenario
• 3.8 Technological landscape
• 3.9 Porter's analysis
• 3.10 Competitive landscape, 2021
  • 3.10.1 Company matrix analysis, 2021
• 3.11 PESTEL analysis

Chapter 4 Home Sleep Apnea Testing Devices Market, By Test Type

• 4.1 Key segment trends
• 4.2 Type 2
  • 4.2.1 Market size, by region, 2017 - 2028 (USD Million)
• 4.3 Type 3
  • 4.3.1 Market size, by region, 2017 - 2028 (USD Million)
• 4.4 Type 4
  • 4.4.1 Market size, by region, 2017 - 2028 (USD Million)

Chapter 5 Home Sleep Apnea Testing Devices Market, By Region

• 5.1 Key regional trends
• 5.2 North America
  • 5.2.1 Market size, by country, 2017 - 2028 (USD Million)
  • 5.2.2 Market size, by test type, 2017 - 2028 (USD Million)
  • 5.2.3 U.S.
    • 5.2.3.1 Market size, by test type, 2017 - 2028 (USD Million)
  • 5.2.4 Canada
    • 5.2.4.1 Market size, by test type, 2017 - 2028 (USD Million)
• 5.3 Europe
  • 5.3.1 Market size, by country, 2017 - 2028 (USD Million)
  • 5.3.2 Market size, by test type, 2017 - 2028 (USD Million)
  • 5.3.3 Germany
    • 5.3.3.1 Market size, by test type, 2017 - 2028 (USD Million)
  • 5.3.4 UK
    • 5.3.4.1 Market size, by test type, 2017 - 2028 (USD Million)
  • 5.3.5 France
    • 5.3.5.1 Market size, by test type, 2017 - 2028 (USD Million)
  • 5.3.6 Italy
    • 5.3.6.1 Market size, by test type, 2017 - 2028 (USD Million)
  • 5.3.7 Spain
    • 5.3.7.1 Market size, by test type, 2017 - 2028 (USD Million)
• 5.4 Asia Pacific
  • 5.4.1 Market size, by country, 2017 - 2028 (USD Million)
  • 5.4.2 Market size, by test type, 2017 - 2028 (USD Million)
  • 5.4.3 China
    • 5.4.3.1 Market size, by test type, 2017 - 2028 (USD Million)
  • 5.4.4 Japan
    • 5.4.4.1 Market size, by test type, 2017 - 2028 (USD Million)
  • 5.4.5 India
    • 5.4.5.1 Market size, by test type, 2017 - 2028 (USD Million)
  • 5.4.6 Australia
    • 5.4.6.1 Market size, by test type, 2017 - 2028 (USD Million)
  • 5.4.7 South Korea
    • 5.4.7.1 Market size, by test type, 2017 - 2028 (USD Million)
• 5.5 Latin America
  • 5.5.1 Market size, by country, 2017 - 2028 (USD Million)
  • 5.5.2 Market size, by test type, 2017 - 2028 (USD Million)
  • 5.5.3 Brazil
    • 5.5.3.1 Market size, by test type, 2017 - 2028 (USD Million)
  • 5.5.4 Mexico
    • 5.5.4.1 Market size, by test type, 2017 - 2028 (USD Million)
  • 5.5.5 Argentina
    • 5.5.5.1 Market size, by test type, 2017 - 2028 (USD Million)
• 5.6 Middle East & Africa
  • 5.6.1 Market size, by country, 2017 - 2028 (USD Million)
  • 5.6.2 Market size, by test type, 2017 - 2028 (USD Million)
  • 5.6.3 South Africa
    • 5.6.3.1 Market size, by test type, 2017 - 2028 (USD Million)
  • 5.6.4 Saudi Arabia
    • 5.6.4.1 Market size, by test type, 2017 - 2028 (USD Million)
  • 5.6.5 UAE
    • 5.6.5.1 Market size, by test type, 2017 - 2028 (USD Million)

Chapter 6 Company Profiles

• 6.1 Competitive dashboard, 2021
• 6.2 Compumedics Limited
  • 6.2.1 Business overview
  • 6.2.2 Financial data
  • 6.2.3 Product landscape
  • 6.2.4 Strategic outlook
  • 6.2.5 SWOT analysis
• 6.3 Cadwell Laboratories Inc.
  • 6.3.1 Business overview
  • 6.3.2 Financial data
  • 6.3.3 Product landscape
  • 6.3.4 Strategic outlook
  • 6.3.5 SWOT analysis
• 6.4 CleveMed
  • 6.4.1 Business overview
  • 6.4.2 Financial data
  • 6.4.3 Product landscape
  • 6.4.4 Strategic outlook
  • 6.4.5 SWOT analysis
• 6.5 Contec Medical Systems
  • 6.5.1 Business overview
  • 6.5.2 Financial data
  • 6.5.3 Product landscape
  • 6.5.4 Strategic outlook
  • 6.5.5 SWOT analysis
• 6.6 Itamar Medical Inc.
  • 6.6.1 Business overview
  • 6.6.2 Financial data
  • 6.6.3 Product landscape
  • 6.6.4 Strategic outlook
  • 6.6.5 SWOT analysis
• 6.7 Koninklijke Philips N.V.
  • 6.7.1 Business overview
  • 6.7.2 Financial data
  • 6.7.3 Product landscape
  • 6.7.4 Strategic outlook
  • 6.7.5 SWOT analysis
• 6.8 Natus Medical Inc.
  • 6.8.1 Business overview
  • 6.8.2 Financial data
  • 6.8.3 Product landscape
  • 6.8.4 Strategic outlook
  • 6.8.5 SWOT analysis
• 6.9 Neurosoft
  • 6.9.1 Business overview
  • 6.9.2 Financial data
  • 6.9.3 Product landscape
  • 6.9.4 Strategic outlook
  • 6.9.5 SWOT analysis
• 6.10 NeuroVirtual/SleepVirtual
  • 6.10.1 Business overview
  • 6.10.2 Financial data
  • 6.10.3 Product landscape
  • 6.10.4 Strategic outlook
  • 6.10.5 SWOT analysis
• 6.11 Nihon Kohden Corporation
  • 6.11.1 Business overview
  • 6.11.2 Financial data
  • 6.11.3 Product landscape
  • 6.11.4 Strategic outlook
  • 6.11.5 SWOT analysis
• 6.12 Nox Medical
  • 6.12.1 Business overview
  • 6.12.2 Financial data
  • 6.12.3 Product landscape
  • 6.12.4 Strategic outlook
  • 6.12.5 SWOT analysis
• 6.13 Resmed
  • 6.13.1 Business overview
  • 6.13.2 Financial data
  • 6.13.3 Product landscape
  • 6.13.4 Strategic outlook
  • 6.13.5 SWOT analysis
• 6.14 SleepMed
  • 6.14.1 Business overview
  • 6.14.2 Financial data
  • 6.14.3 Product landscape
  • 6.14.4 Strategic outlook
  • 6.14.5 SWOT analysis
• 6.15 SOMNOmedics GmbH
  • 6.15.1 Business overview
  • 6.15.2 Financial data
  • 6.15.3 Product landscape
  • 6.15.4 Strategic outlook
  • 6.15.5 SWOT analysis